Friess Associates’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-41,200	Closed	-$15.4M	–	145
2018 Q4	$15.4M	Sell	41,200 -8,350	-17%	-$3.12M	1.32%	35
2018 Q3	$20M	Buy	49,550 +26,550	+115%	+$10.7M	1.4%	33
2018 Q2	$7.94M	Buy	+23,000	New	+$7.94M	0.63%	60